Baier C, Schwarz T, Schaumburger J, Leiß F, Grifka J, Maderbacher G
Orthopädische Klinik für die Universität Regensburg, Asklepios Klinikum Bad Abbach, Kaiser-Karl V.-Allee 3, 93077, Bad Abbach, Deutschland.
Z Rheumatol. 2018 Dec;77(10):874-881. doi: 10.1007/s00393-018-0528-0.
Surgical management of rheumatic feet has dramatically changed over the last decades influenced by the development of new pharmacological drugs and tissue-preserving surgical procedures. It has switched from joint resection to joint-sparing procedures as the method of choice. Nevertheless, the surgical interventions commonly used for non-rheumatic patients cannot be applied to rheumatic patients without reflection: in addition to the basic treatment, comorbidities, degree of mobilization of the patient, orthopedic shoe engineering and orthotic treatment play a major role. Due to the decreasing incidence of the classical rheumatic foot, it has become even more important for physicians, physiotherapists and ergotherapists to recognize the development of such a disease as early as possible and immediately start the appropriate treatment.
在过去几十年里,受新型药物和保留组织手术方法发展的影响,风湿性足部疾病的外科治疗发生了巨大变化。它已从关节切除术转向以保留关节手术为首选方法。然而,常用于非风湿性患者的外科干预措施不能不加思考地应用于风湿性患者:除基础治疗外,合并症、患者的活动程度、矫形鞋设计和矫形治疗也起着重要作用。由于经典风湿性足部疾病的发病率不断下降,医生、物理治疗师和职业治疗师尽早识别这种疾病的发展并立即开始适当治疗变得更加重要。